PT  - JOURNAL ARTICLE
AU  - MIKIO KAWAMURA
AU  - KOJI TANAKA
AU  - YUJI TOIYAMA
AU  - YOSHINAGA OKUGAWA
AU  - MASATO OKIGAMI
AU  - HIROMI YASUDA
AU  - SUSUMU SAIGUSA
AU  - MASAKI OHI
AU  - YASUHIRO INOUE
AU  - KEIICHI UCHIDA
AU  - YASUHIKO MOHRI
AU  - MASATO KUSUNOKI
TI  - Clinical Significance of Tartrate-resistant Acid Phosphatase Type-5 Expression in Human Gastric Cancer
DP  - 2014 Jul 01
TA  - Anticancer Research
PG  - 3425--3429
VI  - 34
IP  - 7
4099  - http://ar.iiarjournals.org/content/34/7/3425.short
4100  - http://ar.iiarjournals.org/content/34/7/3425.full
SO  - Anticancer Res2014 Jul 01; 34
AB  - Aim: The present study investigated the clinical significance of tartrate-resistant acid phosphatase type-5 (ACP5) expression in gastric cancer. Materials and Methods: In 150 specimens of gastric cancer and adjacent normal mucosa, expression of ACP5 protein and mRNA and was determined by immunohistochemical staining and quantitative real-time polymerase chain reaction, respectively. Results: Expression of ACP5 mRNA was significantly higher in cancer tissues than in adjacent normal mucosa. Elevated ACP5 mRNA was associated with lymph node metastasis and peritoneal dissemination. Logistic regression analysis revealed that elevated ACP5 expression was an independent risk factor for peritoneal dissemination and was associated with shorter survival. Immunohistochemical staining of primary carcinomas showed ACP5 to be expressed mainly in the cytoplasm. Conclusion: ACP5 is predictive of peritoneal dissemination in patients with gastric cancer, and might play a crucial role in the establishment of peritoneal dissemination.